BIM
IMMU

BlackRock Investment Management’s Immunomedics Inc IMMU Stock Holding History

BlackRock Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.32M Buy
360,037
+6,926
+2% +$20.5K ﹤0.01% 2506
2016
Q3 		$1.15M Buy
353,111
+3,810
+1% +$10.7K ﹤0.01% 2574
2016
Q2 		$810K Buy
349,301
+4,216
+1% +$14.1K ﹤0.01% 2773
2016
Q1 		$863K Buy
345,085
+6,789
+2% +$15.3K ﹤0.01% 2584
2015
Q4 		$1.04M Buy
338,296
+3,102
+0.9% +$8.66K ﹤0.01% 2578
2015
Q3 		$577K Sell
335,194
-7,414
-2% -$18.9K ﹤0.01% 2967
2015
Q2 		$1.39M Buy
342,608
+97,612
+40% +$399K ﹤0.01% 2522
2015
Q1 		$938K Buy
244,996
+2,528
+1% +$11K ﹤0.01% 2562
2014
Q4 		$1.16M Sell
242,468
-4,554
-2% -$18K ﹤0.01% 2446
2014
Q3 		$919K Buy
247,022
+5,524
+2% +$18.7K ﹤0.01% 2585
2014
Q2 		$881K Buy
241,498
+34,532
+17% +$127K ﹤0.01% 2691
2014
Q1 		$871K Buy
206,966
+476
+0.2% +$2.36K ﹤0.01% 2607
2013
Q4 		$950K Sell
206,490
-4,050
-2% -$18K ﹤0.01% 2545
2013
Q3 		$1.3M Buy
210,540
+11,780
+6% +$67.8K ﹤0.01% 2255
2013
Q2 		$1.08M Buy
+198,760
New +$653K ﹤0.01% 2305

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock Investment Management's IMMU Position: Q4 2016 in Review

BlackRock Investment Management increased its Immunomedics Inc (IMMU) stake by 2% in Q4 2016, buying an estimated $20.5K and bringing the position to 360,037 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

BlackRock Investment Management first reported a position in IMMU in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.39M in Q2 2015. 109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • BlackRock Investment Management held 360,037 shares of Immunomedics Inc worth $1.32M as of Q4 2016.
  • BlackRock Investment Management bought 6,926 Immunomedics Inc shares in Q4 2016, an estimated $20.5K.
  • Immunomedics Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2506 holding.
  • BlackRock Investment Management first reported a position in Immunomedics Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Immunomedics Inc position peaked at $1.39M in Q2 2015.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.